AU505476B2 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
AU505476B2
AU505476B2 AU15413/76A AU1541376A AU505476B2 AU 505476 B2 AU505476 B2 AU 505476B2 AU 15413/76 A AU15413/76 A AU 15413/76A AU 1541376 A AU1541376 A AU 1541376A AU 505476 B2 AU505476 B2 AU 505476B2
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU15413/76A
Other languages
English (en)
Other versions
AU1541376A (en
Inventor
E Scheiffele
G Weickgenannt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henning Berlin GmbH Chemie- und Pharmawerk
Original Assignee
Henning Berlin GmbH Chemie- und Pharmawerk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henning Berlin GmbH Chemie- und Pharmawerk filed Critical Henning Berlin GmbH Chemie- und Pharmawerk
Publication of AU1541376A publication Critical patent/AU1541376A/en
Application granted granted Critical
Publication of AU505476B2 publication Critical patent/AU505476B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU15413/76A 1975-12-10 1976-06-29 Pharmaceutical composition Expired AU505476B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEDE255560 1975-12-10
DE19752555609 DE2555609A1 (de) 1975-12-10 1975-12-10 Pharmazeutisches praeparat zur therapie der hyperurikaemie

Publications (2)

Publication Number Publication Date
AU1541376A AU1541376A (en) 1978-01-05
AU505476B2 true AU505476B2 (en) 1979-11-22

Family

ID=5964014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15413/76A Expired AU505476B2 (en) 1975-12-10 1976-06-29 Pharmaceutical composition

Country Status (8)

Country Link
AU (1) AU505476B2 (fr)
BE (1) BE842389A (fr)
CA (1) CA1048933A (fr)
DE (1) DE2555609A1 (fr)
FR (1) FR2334362A1 (fr)
GB (1) GB1493237A (fr)
NL (1) NL7605531A (fr)
ZA (1) ZA763081B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4660376B2 (ja) * 2003-11-14 2011-03-30 株式会社ヒューマンセルシステムズ 血管障害や高血圧症の治療・予防剤、及びそのスクリーニング方法
US7659424B2 (en) 2004-03-01 2010-02-09 Japan Science And Technology Agency Process for the allylation of n-acylhydrazones
JP2008506785A (ja) * 2004-07-21 2008-03-06 フロリダ大学 リサーチファウンデーション インコーポレイティッド インスリン抵抗性の治療及び予防のための組成物及び方法
US10005750B2 (en) * 2010-10-06 2018-06-26 J-Pharma Co., Ltd. Developing potent urate transporter inhibitors: compounds designed for their uricosuric action
CN103242272B (zh) * 2013-05-22 2016-01-27 合肥医工医药有限公司 一种制备苯溴马隆的方法

Also Published As

Publication number Publication date
NL7605531A (nl) 1977-06-14
BE842389A (fr) 1976-09-16
ZA763081B (en) 1977-04-27
DE2555609A1 (de) 1977-06-30
AU1541376A (en) 1978-01-05
FR2334362A1 (fr) 1977-07-08
GB1493237A (en) 1977-11-30
FR2334362B1 (fr) 1979-08-24
CA1048933A (fr) 1979-02-20

Similar Documents

Publication Publication Date Title
AU497066B2 (en) Photocoplymerizable composition
AU515341B2 (en) Pharmaceutical composition
AU514195B2 (en) Dosage form
ZA7671B (en) Pharmaceutical composition
JPS5272829A (en) Pharmaceutical composition
AU497446B2 (en) Composition
AU502644B2 (en) Xanthine-containing pharmaceutical compositions
AU507272B2 (en) Pharmaceutical compositions and compounds
AU504840B2 (en) Medicinal compositions
AU511364B2 (en) Absorption-refrigerant composition
AU508191B2 (en) Pharmaceutical composition
AU505476B2 (en) Pharmaceutical composition
AU505910B2 (en) Neamatocidal composition
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
AU512090B2 (en) Antiinflammatory pharmaceutical compositions
IE42772L (en) Pharmaceutical compositions
GB1552416A (en) Pharmaceutical compositions
AU498384B2 (en) Anti-timor composition
AU493677B2 (en) Pharmaceutical composition for arteriosclerosis
AU499217B2 (en) Pharmaceutical compositions
IE43955L (en) Pharmaceutical composition
AU488697B2 (en) Pharmaceutical composition
ZA752585B (en) Pharmaceutical composition
AU1287676A (en) New pharmaceutical compositions
AU1172076A (en) Pharmaceutical compositions